The researchers believe that detection of the anti-cancer protein LHPP as a biomarker may allow clinicians to provide better treatment options.
This protein may open up cancer treatment options
HIGHLIGHTS
- This protein prevents the uncontrolled proliferation of cancer cells
- Protein which can stop cancer from progressing identified
- This opens up better treatment options for clinicians
Researchers have discovered a protein that prevents the uncontrolled proliferation of cancer cells in the liver. The anti-cancer protein, called LHPP, can also serve as a biomarker for the diagnosis and prognosis of liver cancer, said the study published in the journal Nature. The incidence of liver cancer, also known as hepatocellular carcinoma, is usually diagnosed at a very late stage when the liver is already severely damaged and hence overall prognosis is poor. The researchers believe that detection of the anti-cancer protein LHPP as a biomarker may allow clinicians to provide better treatment options.
"It is striking that LHPP is present in healthy tissue and completely absent in tumour tissue," said first author Sravanth Hindupur from University of Basel in Switzerland.
In the study conducted in a mouse model for hepatocellular carcinoma, the researchers analysed a total of more than 4,000 proteins, comparing them in healthy and tumour tissue.
The research showed that LHPP emerged as the top favourite.
Re-introduction of the genetic information for LHPP by the researchers was found to prevent the formation of tumours and maintain liver function.
"Similar to the mouse model, we also saw a striking decrease in LHPP levels in tumours of patients with liver cancer," Hindupur said.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.
